Aemetis Inc. buy krebskrebs
Start price
25.01.21
/
50%
€4.10
Target price
25.01.22
€4.50
Performance (%)
101.22%
End price
26.01.22
€8.25
Summary
This prediction ended on 26.01.22 with a price of €8.25. With a performance of 101.22% the BUY prediction by krebskrebs was a big success. krebskrebs has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Aemetis Inc. | -2.568% | -2.568% | -33.440% | -68.809% |
| iShares Core DAX® | 1,43 % | 2,63 % | 12,46 % | 60,35 % |
| iShares Nasdaq 100 | 1,89 % | -0,46 % | 1,25 % | 85,81 % |
| iShares Nikkei 225® | -1,62 % | 11,10 % | 27,38 % | 64,40 % |
| iShares S&P 500 | 1,92 % | 1,16 % | 1,63 % | 59,42 % |
Comments by krebskrebs for this prediction
In the thread Aemetis Inc. diskutieren
In the thread Trading Aemetis Inc.
Die von krebskrebs gewählte maximale Laufzeit wurde überschritten